Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first treatment to slow the progression of Parkinson's disease.
At the Rutgers American Parkinson Disease Association Center for Advanced Research —one of only nine such centers—we don’t just seek to treat the symptoms of Parkinson’s but to cure it. By focusing on ...
A man with a history of Parkinson's and dementia repeatedly fell while in the Jefferson County jail. His family blames his ...
Psilocybin-assisted psychotherapy could lead to significant improvements in anxiety, pessimism, and disease acceptance among those with Parkinson’s disease, according to researchers from the ...
Scientists from the University of Rochester and other research centers have found a strong link between a widely used ...
John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...
They hope these same drugs can restore waste disposal in the brains of older humans and help protect against brain diseases.
King Chulalongkorn Memorial Hospital and Thai Red Cross Society have launched the "Check PD" application for Parkinson's risk screening after statistics show that the disease rate among Thai people ...
Annovis Bio, Inc. (NYSE: ANVS) will hold a live webcast aimed at providing patients, caregivers, and families with updates on ...
When Jim Young (Kellogg ‘90) was diagnosed with Parkinson’s disease five years ago, it made writing a challenge. But after ...
Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...